CHIKV Mutant

Chikungunya Mutant (A226V) E1 Recombinant
Cat. No.
BT343
Source
Insect cells.
Synonyms
Appearance
Sterile filtered colorless solution.
Purity
Protein is >95% pure as determined by 12.5% SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Chikungunya Mutant (A226V) E1 produced in Insect Cells is a polypeptide chain containing amino acids 1-415, however at position 226 the Alanine of the wild-type CHIKV E1 gene was mutated to Valine. The molecular weight of the CHIKV Mutant is approximately 50kDa. The E1 protein is C-terminal part of E2-6K-E1 protein region. CHIKV Mutant is purified by proprietary chromatographic technique.

Product Specs

Introduction

Chikungunya is a viral infection transmitted to humans through the bites of infected Aedes mosquitoes, primarily Aedes albopictus and Aedes aegypti. The virus can also infect animals, including monkeys, birds, cattle, and rodents. Symptoms typically appear 2-4 days after infection and include a sudden onset of fever, often accompanied by joint pain. The fever usually lasts for 2-7 days, while joint pain can persist for weeks, months, or even years. The mortality rate is less than 1 in 1,000. Outbreaks of chikungunya have been reported in Asia, Europe, and the Americas since 2004.

The chikungunya virus (CHIKV) has a single-stranded, positive-sense RNA genome containing approximately 11,800 nucleotides. This genome encodes two open reading frames. The virus's nucleocapsid, which houses the RNA genome, is enclosed within a protective lipid bilayer called the envelope. Embedded within the envelope are approximately 80 glycoprotein spikes, which are anchored to the viral envelope at their C-termini.

The virus produces a structural polyprotein from a subgenomic mRNA. This polyprotein contains the five structural proteins: capsid (C), E3, E2, 6K, and E1. The capsid protein is cleaved from the polyprotein and encapsidates the viral RNA. The remaining envelope polyprotein precursor (E3-E2-6K-E1) is transported to the endoplasmic reticulum, where host enzymes process it into the individual E3, E2, and E1 proteins. These proteins assemble into hetero-trimeric spikes on the virus's surface. The E1 and E2 proteins within these spikes play crucial roles in recognizing host cell receptors, mediating cell entry via pH-dependent endocytosis, and facilitating viral budding.

Description
Recombinant Chikungunya Mutant (A226V) E1 protein, produced in insect cells, is a modified version of the chikungunya virus E1 protein. It encompasses amino acids 1 to 415, with a specific mutation where the Alanine at position 226 in the wild-type CHIKV E1 gene is replaced with Valine. This mutation distinguishes it from the naturally occurring E1 protein. The protein has a molecular weight of approximately 50kDa. It constitutes the C-terminal portion of the E2-6K-E1 protein region. Purification of the CHIKV Mutant protein is achieved using a proprietary chromatographic technique, ensuring its isolation and separation from other cellular components.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The CHIKV Mutant protein is supplied in a solution containing 1x Dulbecco's Phosphate-Buffered Saline (D-PBS) at pH 7.4, 0.1% Thimerosal (a preservative), 5mM EDTA (a chelating agent), and a protease inhibitor cocktail consisting of Leupeptin, Aprotinin, and Pepstatin A, each at a concentration of 1 µg/ml.
Stability
For short-term storage (2-4 weeks), the protein solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. To prevent protein degradation during long-term storage, adding a carrier protein such as 0.1% HSA (human serum albumin) or BSA (bovine serum albumin) is advisable. Repeated freezing and thawing of the protein solution should be avoided to maintain protein stability.
Purity
The purity of the CHIKV Mutant protein is greater than 95%, as determined by SDS-PAGE analysis using a 12.5% polyacrylamide gel.
Source
Insect cells.
Amino Acid Sequence
YEHVTVIPNTVGVPYKTLVNRPGYSPMVLEMELLSVTLEPTLSLDYITCEYKTVIPSPYVKCC
GTAECKDKNLPDYSCKVFTGVYPFMWGGAYCFCDAENTQLSEAHVEKSESCKTEFASAYRAHT
ASASAKLRVLYQGNNITVTAYANGDHAVTVKDAKFIVGPMSSAWTPFDNKIVVYKGDVYNMDYP
PFGAGRPGQFGDIQSRTPESKDVYANTQLVLQRPAVGTVHVPYSQAPSGFKYWLKERGASLQHT
APFGCQIATNPVRAVNCAVGNMPISIDIPEAAFTRVVDAPSLTDMSCEVPACTHSSDFGGVAII
KYAASKKGKCAVHSMTNAVTIREAEIEVEGNSQLQISFSTALASAEFRVQVCSTQVHCAAECHP
PKDHIVNYPASHTTLGQDISATAMSWVQKITGG.

Product Science Overview

Introduction to Chikungunya Virus

Chikungunya virus (CHIKV) is an arthropod-borne virus belonging to the Alphavirus genus within the Togaviridae family. It is primarily transmitted to humans through the bites of infected mosquitoes, particularly Aedes aegypti and Aedes albopictus . The virus causes Chikungunya fever, characterized by sudden onset of fever, severe joint pain, muscle pain, headache, nausea, fatigue, and rash .

Structure and Function of E1 Glycoprotein

The CHIKV virion is enveloped and contains a single-stranded positive-sense RNA genome of approximately 11.8 kilobases. The viral envelope is derived from the host cell’s plasma membrane and includes two major glycoproteins, E1 and E2, along with a small 6K peptide . The E1 glycoprotein plays a crucial role in the virus’s ability to fuse with host cell membranes, facilitating viral entry and infection .

Mutation A226V in E1 Glycoprotein

During the 2005-2006 Chikungunya outbreaks, a significant mutation was identified in the E1 glycoprotein at amino acid position 226, where alanine was replaced by valine (A226V) . This mutation enhanced the virus’s ability to infect and replicate in Aedes albopictus mosquitoes, which are more widespread than Aedes aegypti . Consequently, the A226V mutation increased the epidemic potential of CHIKV by enabling more efficient transmission to human populations .

Recombinant E1 Glycoprotein

Recombinant CHIKV E1 glycoprotein, including the A226V mutant, is produced in insect cells for research purposes . The recombinant protein is a polypeptide chain containing amino acids 1-415, with the alanine at position 226 mutated to valine . This recombinant protein is used in various applications, including enzyme-linked immunosorbent assays (ELISA) and Western blotting, to study the virus’s properties and develop diagnostic tools .

Implications of the A226V Mutation

The A226V mutation has significant implications for CHIKV transmission and epidemiology. By increasing the virus’s ability to infect Aedes albopictus, the mutation has facilitated the spread of CHIKV to new geographic regions where this mosquito species is prevalent . This has led to larger and more widespread outbreaks, posing a greater public health challenge .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.